[1]
A. Latigui, N. K. Bouzidi, N. Hassini, and S. Benmetir, “Exploration of Novel Type 2 Antidiabetic Agents: Molecular Docking and Toxicity Assessment of Polyphenolic Compounds for Improved Therapeutic Potential”, TJNPR, vol. 8, no. 7, pp. 7755–7758, Aug. 2024, doi: 10.26538/tjnpr/v8i7.19.